NL-OMON36912已完成3 期
Prevention of radiation-induced parotid gland dysfunction by parotid-gland stem-cell sparing intensity-modulated radiotherapy (SCS-IMRT) - Parotid gland stem cell sparing radiotherapy
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients treated with planned curative primary radiotherapy for HNC, with or without chemotherapy or cetuximab meeting the following criteria:
- •- Squamous cell carcinoma originating from the mucosa of the head and neck area or nasofaryngeal carcinoma originating from the nasofarynx;
- •- The radiotherapy includes prophylactic or therapeutic irradiation of both sides of the neck (at least level II to IV);
- •- Age * 18 years;
- •- WHO performance 0-2;
- •- pre-treatment stimulated parotid gland saliva production >0.2 ml/min.
排除标准
- •- Postoperative radiotherapy;
- •- Re-irradiation;
- •- Unilateral radiotherapy;
- •- Primary salivary gland tumours
研究者
相似试验
已完成
不适用
Parotid-gland Stem-cell Sparing Intensity-modulated RadiotherapyHead and Neck CancerNCT01955239University Medical Center Groningen106
招募中
3 期
Parotid sparing adaptive radiotherapy in head and neck cancer.CTRI/2023/05/052216Tata Medical Center
招募中
不适用
Parotid Sparing Adaptive RadiotherapyCTRI/2017/11/010683Tata Medical Centre
已完成
不适用
Prophylaxis of radiation-induced oral mucositis in oral cancer patients: multicenter randomized clinical trialoral cancerJPRN-UMIN000011254Department of Oral Health, Nagasaki University Graduate School of Biomedical Sciences120
进行中（未招募）
不适用
Preventative effects of parotid gland massage for salivary gland dysfunction at high-dose radioiodine therapy in patients with differentiated thyroid cancer who had received total thyroidectomyNeoplasmsKCT0003276Kyungpook National University Hospital100